Received Apr 9, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
Menveo administration after expiration date; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 67-year-old male patient who received Men ACWY-CRM NVS (Menveo) (expiry date FEB-2026) for prophylaxis. On 03-APR-2026, the patient received Menveo. On 03-APR-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo administration after expiration date). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 03-APR-2026 The pharmacist did not have information about Menveo presentation (1 or 2 vial). The reporter mentioned that the vaccine expired 2 months ago (lot number and expiration date not provided). The reporter asked for recommendations on this situation. The batch number was not provided upon follow-up with the reporter. No further details were provided.